{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:46:09Z","timestamp":1758815169024},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.leukres.2006.08.023","type":"journal-article","created":{"date-parts":[[2006,9,30]],"date-time":"2006-09-30T11:24:00Z","timestamp":1159615440000},"page":"629-638","source":"Crossref","is-referenced-by-count":11,"title":["Endostatin variations in childhood acute lymphoblastic leukaemia\u2014Comparison with basic fibroblast growth factor and vascular endothelial growth factor"],"prefix":"10.1016","volume":"31","author":[{"given":"P.","family":"Schneider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Corbi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Marie-Cardine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Boquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Cazin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Vannier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2006.08.023_bib1","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1182\/blood.V95.8.2637","article-title":"Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia","volume":"95","author":"Padro","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.08.023_bib2","first-page":"815","article-title":"Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia","volume":"150","author":"Perez-Atayde","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.leukres.2006.08.023_bib3","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1182\/blood.V94.11.3717","article-title":"Cellular VEGF is a predictor of outcome in patients with acute myeloblastic leukemia","volume":"94","author":"Aguayo","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.08.023_bib4","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/cncr.10900","article-title":"Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes","volume":"95","author":"Aguayo","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2006.08.023_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/1024533021000037207","article-title":"Soluble hepatocyte growth factor (sHGF) and vascular endothelial growth factor (sVEGF) in adult acute myeloid leukemia: relationship to disease characteristics","volume":"7","author":"Aref","year":"2002","journal-title":"Hematology"},{"key":"10.1016\/j.leukres.2006.08.023_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/152581602753448586","article-title":"Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia","volume":"11","author":"Brunner","year":"2002","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1016\/j.leukres.2006.08.023_bib7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000046613","article-title":"Angiogenesis in acute myeloid leukemia and myelodysplastic syndrome","volume":"106","author":"Albitar","year":"2001","journal-title":"Acta Haematol"},{"key":"10.1016\/j.leukres.2006.08.023_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/10428190109097679","article-title":"Clinical importance of serum vascular endothelial and basic fibroblast growth factors in children with acute lymphoblastic leukemia","volume":"42","author":"Yetgin","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2006.08.023_bib9","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.leu.2403332","article-title":"Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF","volume":"18","author":"Wellmann","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2006.08.023_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2141.2003.04395_4.x","article-title":"Have urinary levels of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, a prognostic value in childhood acute lymphoblastic leukaemia","volume":"122","author":"Schneider","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2006.08.023_bib11","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1182\/blood-2002-10-2998","article-title":"A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia","volume":"102","author":"Fiedler","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.08.023_bib12","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1080\/1042819031000077043","article-title":"Thalidomide for the treatment of acute myeloid leukemia","volume":"44","author":"Steins","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2006.08.023_bib13","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/sj.leu.2403824","article-title":"Anti-angiogenic treatment with endostatin inhibits progression of AML in vivo","volume":"19","author":"Schuch","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2006.08.023_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0065-230X(05)94005-0","article-title":"Endostatin signaling and regulation of endothelial cell\u2013matrix interactions","volume":"94","author":"Wickstrom","year":"2005","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.leukres.2006.08.023_bib15","first-page":"6052","article-title":"The generation of endostatin is mediated by elastase","volume":"59","author":"Wen","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2006.08.023_bib16","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1091\/mbc.E04-11-1029","article-title":"Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells","volume":"16","author":"Im","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.leukres.2006.08.023_bib17","first-page":"133","article-title":"Immunologic analysis of a thousand cases of acute leukaemia. French Groupe d\u2019Etude Immunologique des Leuc\u00e9mies (GEIL)","volume":"31","author":"Bene","year":"1989","journal-title":"Nouv Rev Fr Hematol"},{"key":"10.1016\/j.leukres.2006.08.023_bib18","first-page":"223","article-title":"Fibronectin increases the migration induced by stromal cell-derived factor 1 alpha (SDF-1\u03b1) in pre-B acute lymphoblastic leukemia cells","volume":"12","author":"Sbaa-Ketata","year":"2001","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.leukres.2006.08.023_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ijc.10566","article-title":"Serum levels of angiogenin, basic fibroblast growth factor and endostatin in patients receiving intensive chemotherapy for acute myelogenous leukaemia","volume":"101","author":"Glenjen","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2006.08.023_bib20","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1161\/01.ATV.19.8.1835","article-title":"Oncostatin M induces angiogenesis in vitro and in vivo","volume":"19","author":"Vasse","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.leukres.2006.08.023_bib21","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12613748","article-title":"HMEC-1: establishment of an immortalized human microvascular endothelial cell line","volume":"99","author":"Ades","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.leukres.2006.08.023_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0945-053X(98)90003-8","article-title":"Complete primary structure of two variant forms of human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts","volume":"16","author":"Saarela","year":"1998","journal-title":"Matrix Biol"},{"key":"10.1016\/j.leukres.2006.08.023_bib23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10434-001-0741-x","article-title":"A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases","volume":"8","author":"Feldman","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.leukres.2006.08.023_bib24","first-page":"4628","article-title":"Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer","volume":"6","author":"Feldman","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2006.08.023_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0169-5002(01)00285-9","article-title":"Serum endostatin correlates with progression and prognosis of non-small cell lung cancer","volume":"35","author":"Suzuki","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.leukres.2006.08.023_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.canlet.2003.09.018","article-title":"Correlation between serum vascular endothelial growth factor and endostatin levels in patients with breast cancer","volume":"204","author":"Zhao","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1016\/j.leukres.2006.08.023_bib27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0090-4295(02)02429-9","article-title":"Serum levels of endostatin and matrix metalloproteinase-9 associated with high stage and grade primary transitional cell carcinoma of the bladder","volume":"61","author":"Guan","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.leukres.2006.08.023_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/00365510260296492","article-title":"Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets","volume":"62","author":"Werther","year":"2002","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.leukres.2006.08.023_bib29","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sj.bjp.0704312","article-title":"Thrombin-induced platelet endostatin release is blocked by a proteinase activated receptor-4 (PAR 4) antagonist","volume":"134","author":"Ma","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.leukres.2006.08.023_bib30","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1083\/jcb.200203064","article-title":"Endostatin is a potential inhibitor of Wnt signaling","volume":"158","author":"Hanai","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1016\/j.leukres.2006.08.023_bib31","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/sj.bjc.6602835","article-title":"Endostatin expression in a pancreatic cell line is modulated by a TNFalpha-dependent elastase","volume":"93","author":"Brammer","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.leukres.2006.08.023_bib32","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1464-410X.2005.05272.x","article-title":"Differential endostatin binding to bladder, prostate and kidney tumour vessels","volume":"95","author":"Schmidt","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.leukres.2006.08.023_bib33","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/sj.leu.2402486","article-title":"Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants","volume":"16","author":"Janowska-Wieczorek","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2006.08.023_bib34","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000067256","article-title":"Low levels of endostatin in the urine from patients with malignant disease","volume":"23","author":"Linder-Stragliotto","year":"2002","journal-title":"Tumour Biol"},{"key":"10.1016\/j.leukres.2006.08.023_bib35","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1096\/fj.99-1083com","article-title":"Antiangiogenesis signals by endostatin","volume":"15","author":"Shichiri","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.leukres.2006.08.023_bib36","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/104303403766682250","article-title":"Endostatin exhibits a direct antitumor effect in addition to its anti-angiogenic activity in colon cancer cells","volume":"14","author":"Dkhissi","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.leukres.2006.08.023_bib37","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/sj.leu.2402467","article-title":"B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules","volume":"16","author":"Kay","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2006.08.023_bib38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/0962935031000134888","article-title":"Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukaemia","volume":"12","author":"Gora-Tybor","year":"2003","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.leukres.2006.08.023_bib39","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1365-2141.1999.01547.x","article-title":"Angiogenic growth factors and endostatin in non-hodgkin's lymphoma","volume":"106","author":"Bertolini","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2006.08.023_bib40","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/cncr.11399","article-title":"Elevated serum endostatin is associated with poor outcome in patients with non-hodgkin lymphoma","volume":"97","author":"Bono","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2006.08.023_bib41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/09629350310001599675","article-title":"High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment","volume":"12","author":"Urbanska-Rys","year":"2003","journal-title":"Mediators Inflamm"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212606003390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212606003390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T11:04:46Z","timestamp":1587207886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212606003390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0145212606003390"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2006.08.023","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}